Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.
Fexofenadine
allergy
antihistamines
clinical trials
drowsiness
non-drowsy
sedation
Journal
Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014
Informations de publication
Date de publication:
19 Jul 2024
19 Jul 2024
Historique:
medline:
19
7
2024
pubmed:
19
7
2024
entrez:
19
7
2024
Statut:
aheadofprint
Résumé
Fexofenadine is a second-generation inverse agonist of H We performed an electronic literature search using keywords such as fexofenadine, drowsiness, somnolence, sedation, fatigue, cognitive, impairment, psychomotor, driving performances, sleep, rapid eye movement, alertness, clinical study, Positron emission tomography (PET) and proportional impairment ratio (PIR) data along with other objective tests from various studies confirmed the non-sedative property of fexofenadine. Results of brain H Published literature based on various parameters and clinical trials conducted for evaluating the effect of fexofenadine on sedation and central nervous system shows fexofenadine is both clinically effective and non-sedating.
Identifiants
pubmed: 39028636
doi: 10.1080/03007995.2024.2378172
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM